Cargando…
Current pharmacologic treatments for smoking cessation and new agents undergoing clinical trials
Smoking causes various diseases and is a major public health threat worldwide. Therefore, promoting smoking cessation is the most important intervention contributing to maintaining the health of smokers and nonsmokers and saving enormous financial expense. We reviewed existing and emerging smoking-c...
Autores principales: | Nagano, Tatsuya, Katsurada, Masahiro, Yasuda, Yuichiro, Kobayashi, Kazuyuki, Nishimura, Yoshihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755639/ https://www.ncbi.nlm.nih.gov/pubmed/31533544 http://dx.doi.org/10.1177/1753466619875925 |
Ejemplares similares
-
Group 2 Innate Lymphoid Cells and the House Dust Mite-Induced Asthma Mouse Model
por: Yasuda, Yuichiro, et al.
Publicado: (2020) -
Eosinophilic Pneumonia Associated With Natalizumab In A Patient With Multiple Sclerosis: A Case Report And Literature Review
por: Yasuda, Yuichiro, et al.
Publicado: (2019) -
Role of S1P/S1PR3 axis in release of CCL20 from human bronchial epithelial cells
por: Kawa, Yoshitaka, et al.
Publicado: (2018) -
Pseudo-Progression and the Neutrophil-to-Lymphocyte Ratio in Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: A Case–Control Study
por: Kiriu, Tatsunori, et al.
Publicado: (2019) -
Crucial Role of Extracellular Vesicles in Bronchial Asthma
por: Nagano, Tatsuya, et al.
Publicado: (2019)